Hanan S. Anbar

Design, synthesis, biological evaluation, and modeling studies of novel conformationally-restricted analogues of sorafenib as selective kinase-inhibitory antiproliferative agents against hepatocellular carcinoma cells

Rawan M. Sbenati, Seyed–Omar Zaraei, Mohammed I. El–Gamal et al. · European Journal of Medicinal Chemistry · 2020 · 34 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Design and synthesis of new quinoline derivatives as selective C-RAF kinase inhibitors with potent anticancer activity

Seyed–Omar Zaraei, Nour N. Alach, Hanan S. Anbar et al. · European Journal of Medicinal Chemistry · 2022 · 32 citations · Full text

Medicine, Medicinal Chemistry, Oncology +14

Synthesis, biological evaluation, and docking studies of new raloxifene sulfonate or sulfamate derivatives as inhibitors of nucleotide pyrophosphatase/phosphodiesterase

Mohammed I. El–Gamal, Saif Ullah, Seyed–Omar Zaraei et al. · European Journal of Medicinal Chemistry · 2019 · 29 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +12

Discovery of first-in-class imidazothiazole-based potent and selective ErbB4 (HER4) kinase inhibitors

Seyed–Omar Zaraei, Rawan M. Sbenati, Nour N. Alach et al. · European Journal of Medicinal Chemistry · 2021 · 29 citations · Full text

Pharmacy, Medicinal Chemistry, Oncology +16

Design and synthesis of novel anti-urease imidazothiazole derivatives with promising antibacterial activity against Helicobacter pylori

Afnan I. Shahin, Sumera Zaib, Seyed–Omar Zaraei et al. · PLoS ONE · 2023 · 28 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16